Posted by Michael Wonder on 18 Feb 2020
Vifor Pharma acquires priority review voucher
17 February 2020 - Vifor Pharma today announced that it has agreed to purchase a US FDA priority review voucher.
A priority review voucher entitles the holder to obtain priority review for a new drug application or biologics license application thereby reducing the target review time and potentially leading to a faster approval.
